| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
121,380,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
2,187 |
2,187 |
98,220 |
| Total Buy Value |
$0 |
$38,963 |
$38,963 |
$2,585,297 |
| Total People Bought |
0 |
1 |
1 |
2 |
| Total Buy Transactions |
0 |
1 |
1 |
4 |
| Total Shares Sold |
100 |
200 |
8,325 |
31,716 |
| Total Sell Value |
$2,787 |
$4,692 |
$233,035 |
$1,293,892 |
| Total People Sold |
1 |
1 |
2 |
3 |
| Total Sell Transactions |
1 |
2 |
6 |
12 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Saia John G. |
See Remarks |
• – – |
2020-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,491 |
15,903 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2020-09-10 |
4 |
AS |
$94.22 |
$471,100 |
D/D |
(5,000) |
4,059 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2020-09-10 |
4 |
OE |
$5.94 |
$29,700 |
D/D |
5,000 |
9,059 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2020-09-08 |
4 |
AS |
$88.69 |
$816,247 |
D/D |
(9,146) |
4,643 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2020-09-08 |
4 |
OE |
$4.18 |
$38,230 |
D/D |
9,146 |
13,789 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2020-09-02 |
4 |
AS |
$92.17 |
$7,060,961 |
D/D |
(75,000) |
2,614,532 |
|
- |
|
| Bertocci Derek A |
Chief Financial Officer |
• – – |
2020-09-01 |
4 |
AS |
$93.64 |
$2,827,454 |
D/D |
(30,100) |
6,373 |
|
- |
|
| Bertocci Derek A |
Chief Financial Officer |
• – – |
2020-08-17 |
4 |
AS |
$85.30 |
$2,194,005 |
D/D |
(25,000) |
36,473 |
|
- |
|
| Kaul Samir |
Director |
– • – |
2020-08-17 |
4 |
AS |
$85.18 |
$875,848 |
I/I |
(10,000) |
71,943 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2020-08-10 |
4 |
AS |
$87.00 |
$435,000 |
D/D |
(5,000) |
4,059 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2020-08-10 |
4 |
OE |
$5.94 |
$29,700 |
D/D |
5,000 |
9,059 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2020-08-04 |
4 |
AS |
$83.89 |
$1,262,877 |
D/D |
(15,000) |
2,689,532 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2020-08-04 |
4 |
OE |
$4.18 |
$62,700 |
D/D |
15,000 |
2,704,532 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2020-08-03 |
4 |
AS |
$85.27 |
$5,175,768 |
D/D |
(60,000) |
2,689,532 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2020-08-03 |
4 |
OE |
$4.18 |
$250,800 |
D/D |
60,000 |
2,749,532 |
|
- |
|
| Bertocci Derek A |
Chief Financial Officer |
• – – |
2020-08-01 |
4 |
D |
$85.18 |
$60,819 |
D/D |
(714) |
61,473 |
|
- |
|
| Saia John G. |
See Remarks |
• – – |
2020-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
12,412 |
12,412 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2020-07-10 |
4 |
AS |
$86.66 |
$519,960 |
D/D |
(6,000) |
4,059 |
|
- |
|
| Meresman Stanley J |
Director |
– • – |
2020-07-10 |
4 |
OE |
$5.94 |
$35,640 |
D/D |
6,000 |
10,059 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2020-07-06 |
4 |
AS |
$83.99 |
$1,691,001 |
D/D |
(20,108) |
2,689,532 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2020-07-06 |
4 |
OE |
$4.18 |
$84,051 |
D/D |
20,108 |
2,709,640 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2020-07-02 |
4 |
AS |
$83.48 |
$4,603,794 |
D/D |
(54,892) |
2,689,532 |
|
- |
|
| Talasaz Amirali |
Chairman, President and COO |
• • – |
2020-07-02 |
4 |
OE |
$4.18 |
$229,449 |
D/D |
54,892 |
2,744,424 |
|
- |
|
| Kaul Samir |
Director |
– • – |
2020-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,757 |
4,059 |
|
- |
|
| Gadde Vijaya |
Director |
– • – |
2020-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
4,703 |
4,703 |
|
- |
|
707 Records found
|
|
Page 17 of 29 |
|
|
